Home/Filings/4/0001929354-23-000012
4//SEC Filing

Caissa Capital Management ltd. 4

Accession 0001929354-23-000012

CIK 0001534120other

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 4:22 PM ET

Size

5.8 KB

Accession

0001929354-23-000012

Insider Transaction Report

Form 4
Period: 2023-05-31
Transactions
  • Purchase

    Common Stock

    2023-05-31$2.87/sh+844$2,4221,386,215 total(indirect: See Footnote (1))
Holdings
  • Common Stock

    182,300
Footnotes (2)
  • [F1]Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
  • [F2]These shares are directly owned by Mr. Golestaneh in his personal capacity.

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother
IncorporatedVirgin Islands, British

Related Parties

1
  • filerCIK 0001929354

Filing Metadata

Form type
4
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:22 PM ET
Size
5.8 KB